ATE88894T1 - Methode zur behandlung von kachexie und bestimmte dafuer anzuwendende verbindungen. - Google Patents

Methode zur behandlung von kachexie und bestimmte dafuer anzuwendende verbindungen.

Info

Publication number: ATE88894T1
Authority: AT; Austria
Prior art keywords: hydrogen; alkyl; cachexia; treatment; halogen
Prior art date: 1988-06-16

Application number

AT89306147T

Other languages

English (en)

Inventor

Yo Takiguchi

Jun Ohsumi

Yasuo Shimoji

Kazuhiko Sasagawa

Original Assignee

Sankyo Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-06-16

Filing date

1989-06-16

Publication date

1993-05-15

1989-06-16 Application filed by Sankyo Co filed Critical Sankyo Co

1993-05-15 Application granted granted Critical

1993-05-15 Publication of ATE88894T1 publication Critical patent/ATE88894T1/de

Links

150000001875 compounds Chemical class 0.000 title abstract 3
206010006895 Cachexia Diseases 0.000 title abstract 2
238000011282 treatment Methods 0.000 title abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 5
239000001257 hydrogen Substances 0.000 abstract 5
125000000217 alkyl group Chemical group 0.000 abstract 4
150000002431 hydrogen Chemical class 0.000 abstract 4
229910052736 halogen Inorganic materials 0.000 abstract 3
150000002367 halogens Chemical class 0.000 abstract 3
125000003118 aryl group Chemical group 0.000 abstract 2
125000000753 cycloalkyl group Chemical group 0.000 abstract 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
125000003342 alkenyl group Chemical group 0.000 abstract 1
125000000304 alkynyl group Chemical group 0.000 abstract 1
125000003710 aryl alkyl group Chemical group 0.000 abstract 1
OUUQCZGPVNCOIJ-UHFFFAOYSA-N hydroperoxyl Chemical compound O[O] OUUQCZGPVNCOIJ-UHFFFAOYSA-N 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000000547 substituted alkyl group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Diabetes (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Storage Of Fruits Or Vegetables (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT89306147T 1988-06-16 1989-06-16 Methode zur behandlung von kachexie und bestimmte dafuer anzuwendende verbindungen. ATE88894T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP14913788		1988-06-16
EP89306147A EP0347252B1 (de)	1988-06-16	1989-06-16	Methode zur Behandlung von Kachexie und bestimmte dafür anzuwendende Verbindungen

Publications (1)

Publication Number	Publication Date
ATE88894T1 true ATE88894T1 (de)	1993-05-15

Family

ID=15468558

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT92201695T ATE121744T1 (de)	1988-06-16	1989-06-16	Neue triazolopyrimidin- und pyrazolopyrimidinderivate zur behandlung von kachexie.
AT89306147T ATE88894T1 (de)	1988-06-16	1989-06-16	Methode zur behandlung von kachexie und bestimmte dafuer anzuwendende verbindungen.

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AT92201695T ATE121744T1 (de)	1988-06-16	1989-06-16	Neue triazolopyrimidin- und pyrazolopyrimidinderivate zur behandlung von kachexie.

Country Status (9)

Country	Link
US (2)	US5055479A (de)
EP (2)	EP0508549B1 (de)
JP (1)	JPH0276880A (de)
KR (1)	KR910000737A (de)
AT (2)	ATE121744T1 (de)
CA (1)	CA1329199C (de)
DE (2)	DE68906309T2 (de)
ES (1)	ES2057126T3 (de)
IE (2)	IE930392L (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1330079C (en) *	1988-10-13	1994-06-07	Michihiko Tsujitani	Pyrrolo (3,2-e)pyrazolo(1,5-a)pyrimidine derivative and medicine comprising the same
US5264220A (en) *	1991-11-12	1993-11-23	Long David M Jr	Method of extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents
JPH10218881A (ja) *	1997-02-03	1998-08-18	Pola Chem Ind Inc	新規なピロロピラゾロピリミジン誘導体
TWI271406B (en)	1999-12-13	2007-01-21	Eisai Co Ltd	Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same
US20020061897A1 (en)	2000-03-30	2002-05-23	Elliott Richard L.	Neuropeptide Y antagonists
JP2002043785A (ja)	2000-07-28	2002-02-08	Murata Mfg Co Ltd	シールドケース及びそれを用いた電子機器及びそれを用いた電子装置及びシールドケースの製造方法
DZ3415A1 (fr)	2000-08-31	2002-03-07	Chiron Corp	Guanidinobenzamides comme mc4-r agonistes.
PT1385823E (pt)	2001-04-09	2007-01-31	Novartis Vaccines & Diagnostic	Compostos de guanidino como agonistas do receptor de melanocortina-4 (r-mc4)
DK1433480T3 (da) *	2001-07-13	2011-04-11	Btg Internat Ltd Company	Lægemiddel indeholdende pyrimidin-derivat
US20030195187A1 (en) *	2002-02-04	2003-10-16	Chiron Corporation	Guanidino compounds
US20050124652A1 (en) *	2002-02-04	2005-06-09	Rustum Boyce	Guanidino compounds
US20030207814A1 (en) *	2002-02-04	2003-11-06	Chiron Corporation	Novel guanidinyl derivatives
US20070004743A1 (en) *	2002-02-25	2007-01-04	Xiao Linda L	Intranasal administration of mc4-r agonists
DE60333937D1 (de) *	2002-05-23	2010-10-07	Novartis Vaccines & Diagnostic	Substituierte quinazolinone verbindungen
US7051505B2 (en) *	2002-08-21	2006-05-30	Greg Brannstrom	Tomato harvester
US7329658B2 (en) *	2003-02-06	2008-02-12	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
US7176210B2 (en) *	2003-02-10	2007-02-13	Pfizer Inc.	Cannabinoid receptor ligands and uses thereof
KR20060018217A (ko) *	2003-05-23	2006-02-28	카이론 코포레이션	Ｍｃ4-ｒ 작용제로서 구아니디노-치환된 퀴나졸리논 화합물
US20050009919A1 (en) *	2003-07-07	2005-01-13	Clouatre Dallas L.	Treating cachexia and excessive catabolism with (-)-hydroxycitric acid
WO2005051391A1 (en) *	2003-11-19	2005-06-09	Chiron Corporation	Quinazolinone compounds with reduced bioaccumulation
US8257684B2 (en) *	2008-03-26	2012-09-04	Neurosigma, Inc.	Methods for identifying and targeting autonomic brain regions
BRPI0911659B8 (pt)	2008-04-15	2021-05-25	Eisai R&D Man Co Ltd	composto 3-fenilpirazolo[5,1-b]tiazol e composição farmacêutica compreendendo o mesmo
GB0917774D0 (en) *	2009-10-09	2009-11-25	Senexis Ltd	Novel pharmaceutical compounds
GB0917775D0 (en)	2009-10-09	2009-11-25	Btg Int Ltd	Novel pharmaceutical compounds
WO2012027239A1 (en) *	2010-08-23	2012-03-01	Schering Corporation	NOVEL PYRAZOLO[1,5-a]PYRROLO[3,2-e]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
KR20160101398A (ko)	2015-02-17	2016-08-25	순천대학교 산학협력단	바륨타이타네이트층을 포함하는 복합 세라믹 전극의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS51141896A (en) *	1975-05-31	1976-12-07	Sankyo Co Ltd	Process for preparing fused ring triazoropyrimidine derivatives
DE2704030A1 (de) *	1976-02-12	1977-08-18	Sandoz Ag	Neue organische verbindungen, ihre herstellung und verwendung
JPS5353697A (en) *	1976-10-20	1978-05-16	Sankyo Co Ltd	Tricyclic triazolopyrimidine derivatives
US4619933A (en) *	1979-09-28	1986-10-28	The Upjohn Company	6-aryl pyrimidines for treating aplastic anemia
GB2138418B (en) *	1982-02-19	1985-12-04	Mochida Pharm Co Ltd	Novel s-triazole(1,5-a)pyrimidine derivatives
CA1330079C (en) *	1988-10-13	1994-06-07	Michihiko Tsujitani	Pyrrolo (3,2-e)pyrazolo(1,5-a)pyrimidine derivative and medicine comprising the same

1989
- 1989-06-14 JP JP1149578A patent/JPH0276880A/ja active Pending
- 1989-06-14 US US07/365,851 patent/US5055479A/en not_active Expired - Fee Related
- 1989-06-16 DE DE89306147T patent/DE68906309T2/de not_active Expired - Fee Related
- 1989-06-16 CA CA000603102A patent/CA1329199C/en not_active Expired - Fee Related
- 1989-06-16 IE IE930392A patent/IE930392L/xx unknown
- 1989-06-16 IE IE196389A patent/IE62915B1/en not_active IP Right Cessation
- 1989-06-16 KR KR1019890008349A patent/KR910000737A/ko not_active Ceased
- 1989-06-16 AT AT92201695T patent/ATE121744T1/de not_active IP Right Cessation
- 1989-06-16 ES ES89306147T patent/ES2057126T3/es not_active Expired - Lifetime
- 1989-06-16 EP EP92201695A patent/EP0508549B1/de not_active Expired - Lifetime
- 1989-06-16 AT AT89306147T patent/ATE88894T1/de active
- 1989-06-16 EP EP89306147A patent/EP0347252B1/de not_active Expired - Lifetime
- 1989-06-16 DE DE68922408T patent/DE68922408D1/de not_active Expired - Lifetime
1991
- 1991-04-25 US US07/691,542 patent/US5086057A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0347252A2 (de)	1989-12-20
EP0508549A2 (de)	1992-10-14
IE62915B1 (en)	1995-03-08
EP0347252A3 (de)	1991-03-27
EP0347252B1 (de)	1993-05-05
IE891963L (en)	1989-12-16
ATE121744T1 (de)	1995-05-15
JPH0276880A (ja)	1990-03-16
EP0508549B1 (de)	1995-04-26
EP0508549A3 (de)	1992-11-25
DE68906309D1 (de)	1993-06-09
DE68906309T2 (de)	1994-01-05
US5086057A (en)	1992-02-04
US5055479A (en)	1991-10-08
DE68922408D1 (de)	1995-06-01
CA1329199C (en)	1994-05-03
IE930392L (en)	1989-12-16
KR910000737A (ko)	1991-01-30
ES2057126T3 (es)	1994-10-16

Publication	Publication Date	Title
ATE88894T1 (de)	1993-05-15	Methode zur behandlung von kachexie und bestimmte dafuer anzuwendende verbindungen.
ATE139783T1 (de)	1996-07-15	Azasteroide zur behandlung prostatischer hypertrophie, ihre herstellung und verwendung
DE68914292D1 (de)	1994-05-11	Zusammensetzung zur Behandlung von ischämischen Störungen in Organen.
EP0262399A3 (en)	1989-04-26	Cyclic enol derivatives, production and use thereof
DE69329887D1 (de)	2001-03-01	Thienobenzodiazepinderivate zur Behandlung von Störungen des Zentralnervensystems
EP0725074A3 (de)	1996-11-20	Verbindungen zur Verwendung also Zwischenprodukte zur Herstellung von Androst-3,5-dien-3-carboxy-Derivaten
ATE52916T1 (de)	1990-06-15	Zubereitungen zur behandlung von mycoplasmosen und bakteriellen erkrankungen bei gefluegel.
ATE79257T1 (de)	1992-08-15	Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
ATE102482T1 (de)	1994-03-15	Verwendung von 1,4-disubstituierten-piperidinyl- verbindungen zur herstellung eines arzneimittels zur behandlung von schlaflosigkeit.
ATE92316T1 (de)	1993-08-15	Verwendung von l-carnitinderivaten zur herstellung eines arzneimittels zur therapeutischen behandlung von peripheren neuropathien.
DE68903907D1 (de)	1993-01-28	Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
DE3775666D1 (de)	1992-02-13	Hydroxybutenolid-derivate, ihre herstellung und ihre verwendung.
RO92245A (ro)	1987-07-30	Procedeu pentru prepararea unor derivati de 1,6-naftiridina
DE3752272D1 (de)	1999-05-27	Verwendung eines Thioesters zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Ischämie und von Reperfusion-Syndromen
ATE38982T1 (de)	1988-12-15	Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel.
PT84157A (en)	1987-02-01	Process for preparing heptanoyl-glu-asp-ala-amino acid immunostimmulants
NO173991C (no)	1994-03-02	Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater
ATE110568T1 (de)	1994-09-15	Pharmazeutisches präparat zur behandlung des katarakts.
DE68922596D1 (de)	1995-06-14	3-(3-Ethyl-1,2,4-oxadiazol-5-yl)-1-azabicycloheptan, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Zubereitungen.
DE3574675D1 (de)	1990-01-18	Verfahren zum sterilisieren von rekombinantem mikroorganismus.
ATE186912T1 (de)	1999-12-15	Carbamoylpyrrolidon-derivate zur behandlung von depressionen und cerebrovasculären störungen
SE8702697D0 (sv)	1987-06-30	Method of treating ischaemic vascular diseases
ATE81466T1 (de)	1992-10-15	Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
ATE81465T1 (de)	1992-10-15	Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.